CoChat

Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women

Raffone, Emanuela, Rizzo, Pietro, Benedetto, Vincenzo · 2010 · Gynecological Endocrinology

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: The aim of this study was to compare the effectiveness of myo-inositol (MYO) and metformin, in monotherapy or in association with recombinant follicle stimulating hormone (r-FSH), in the treatment of menstrual irregularities, chronic anovulation, and female infertility in patients with polycystic ovary syndrome (PCOS). MATERIALS AND METHODS: One hundred twenty patients were randomly treated with metformin 1500 mg/day orally (n = 60), or 4 g MYO plus 400 microg folic acid daily (n = 60), continuously. If no pregnancy occurred, r-FSH (37.5 units/day) was added to the treatment for a maximum of three attempts. RESULTS: Fifty percent of the patients who assumed metformin restored spontaneous ovulation, 18.3% of these obtained pregnancy. The remaining 42 patients were treated with metformin plus r-FSH. Pregnancy occurred in a total of 11 women (26.1%). The total pregnancy rate was 36.6%. Sixty-five percent of the patients treated with MYO plus folic acid restored spontaneous ovulation activity, 30% of these obtained pregnancy. The remaining 38 patients were treated with MYO, folic acid plus r-FSH. Pregnancy occurred in a total of 11 women (28.9%). The total pregnancy rate was 48.4%. CONCLUSIONS: Both metformin and MYO, can be considered as first line treatment for restoring normal menstrual cycles in most patients with PCOS, even if MYO treatment seems to be more effective than metformin.

Overview

Integrity signals

Registry

Crossref · 10.3109/09513590903366996

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 more claim about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Citations

Cites

2 retracted

Show all 32 references

Research works printed but not linked: 1

  1. 10.1016/j.bpobgyn.2004.05.005 · DOI

Cited by

See all 100

Metadata

Authors
Raffone, E., Rizzo, P., & Benedetto, V.
Affiliations
Azienda Ospedaliera Universitaria Policlinico "G. Martino" (IT)
Corresponding author
Raffone, Emanuela
Venue
Gynecological Endocrinology
Published
2009-11-09
Volume
26
Issue
4
Pages
275-280
ISSN
  • 0951-3590 (ISSN-L)
  • 1473-0766
OpenAlex
W2150739827
Cited by
100
References
32
Citations by year
2026: 3 · 2025: 5 · 2024: 5 · 2023: 10 · 2022: 7 · 2021: 9 · 2020: 10 · 2019: 7 · 2018: 11 · 2017: 11 · 2016: 4 · 2015: 1 · 2014: 4 · 2013: 5 · 2012: 2
FWCI
3.14
Type
journal article
Language
en
Open access
closed
Locations
  • Gynecological Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
  • Health Sciences › Medicine › Reproductive Medicine › Reproductive Health and Technologies
Keywords
polycystic ovary syndrome, myo-inositol, metformin, insulin sensitizers, recombinant FSH, ovulation induction, female infertility, anovulation, menstrual irregularity, pregnancy rate, folic acid
MeSH terms
Adult, Anovulation, Drug Therapy, Combination, Female, Fertility Agents, Female, Folic Acid, Follicle Stimulating Hormone, Humans, Hypoglycemic Agents, Infertility, Female, Inositol, Menstruation Disturbances, Metformin, Ovulation Induction, Polycystic Ovary Syndrome, Pregnancy, Pregnancy Rate, Dietary Supplements, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women. https://app.cochat.ai/papers/10.3109/09513590903366996
The paper
Raffone, E., Rizzo, P., & Benedetto, V. (2010). Insulin sensitiser agents alone and in co-treatment with r-FSH for ovulation induction in PCOS women. Gynecological Endocrinology. https://doi.org/10.3109/09513590903366996

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.